Consortium Disclaimer
This website is maintained to keep the public informed about the activities of the PROTECT consortium. Our goal is to keep this information and material timely and accurate. If errors are brought to our attention, we will try to correct them. However, the consortium accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage that might occur to you and/or any other third party) arising out of or in connection with the information on this site, including the documents published on this site. In particular, the consortium is indemnified from and against all costs, proceedings, claims, expenses and liabilities whatsoever arising from any breach by any legal or natural person as a result of any representation or warranty providing to be a misrepresentation. The information provided on this website is sometimes linked to external sites over which the consortium has no control and for which the consortium assumes no responsibility. Once you visit an external website you are subject to the policies of that site. It is our goal to minimise disruption caused by technical errors. However, some data or information on our website may have been created or structured in files or formats that are not error-free and we cannot guarantee that our service will not be interrupted or otherwise affected by such problems. The consortium accepts no responsibility whatsoever with regard to such problems incurred as a result of using this website.
PROTECT Benefit-Risk Group Disclaimer
The processes described and conclusions drawn from the work presented herein relate solely to the testing of methodologies and representations for the evaluation of benefit and risk of medicines. This report neither replaces nor is intended to replace or comment on any regulatory decisions made by national regulatory agencies, nor the European Medicines Agency.
Acknowledgements
The research leading to these results was conducted as part of the PROTECT consortium (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium, www.imi-protect.eu) which is a public-private partnership coordinated by the European Medicines Agency. The PROTECT project has received support from the Innovative Medicine Initiative Joint Undertaking (www.imi.europa.eu) under Grant Agreement n°115004, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution.